Causal relationship between osteoarthritis with atrial fibrillation and coronary atherosclerosis: a bidirectional

Meng Yin1, Wenchang Xu2,3, Jixiang Pang4

  • 1Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.

Insights

Osteoarthritis (OA) increases the risk of atrial fibrillation (AF). However, osteoarthritis and coronary atherosclerosis (CA) appear to have a mutually protective relationship, suggesting complex cardiovascular interactions.

Area of Science:

  • Genetics and Epidemiology
  • Cardiovascular Medicine
  • Rheumatology

Background:

  • Osteoarthritis (OA) is a prevalent degenerative condition.
  • Observational studies suggest a link between OA and cardiovascular diseases (CVD), including atrial fibrillation (AF) and coronary atherosclerosis (CA).
  • Robust evidence confirming the OA-CVD association is limited.

Purpose of the Study:

  • To investigate the causal relationship between osteoarthritis and cardiovascular diseases, specifically atrial fibrillation and coronary atherosclerosis.
  • To utilize a bidirectional two-sample Mendelian randomization approach to assess these associations.

Main Methods:

  • A bidirectional two-sample Mendelian randomization study was conducted.
  • Data for OA were integrated from UK Biobank and arcogen (n=417,596).
  • Data for AF (n=1,030,836) and CA (n=218,792) were obtained from large-scale genetic studies.
  • Inverse variance weighted (IVW) method was the primary analysis, supplemented by MR Egger and weighted median methods. Sensitivity analyses included Cochran Q statistic and leave-one-out analysis.

Main Results:

  • Osteoarthritis was found to be a risk factor for atrial fibrillation (IVW: OR 1.11, P=0.002).
  • A negative association was observed between osteoarthritis and coronary atherosclerosis (IVW: OR 0.88, P=0.02).
  • Reverse analyses indicated no significant effect of AF on OA, but confirmed a negative association between CA and OA (IVW: OR 0.95, P=0.01).

Conclusions:

  • This study provides genetic evidence that osteoarthritis is a risk factor for atrial fibrillation.
  • A mutually protective relationship exists between osteoarthritis and coronary atherosclerosis.
  • Further research is needed to elucidate the underlying biological mechanisms driving these associations.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12